CN6 - E-health effectiveness to increase patient adherence for immunotherapy: A cost-benefit study

Dias, M.J.S. ; Fernández, P. ; Sousa, P. ; Rocha Gonçalves, F. ; Férnandez, E.

Elsevier Ltd

Texto completo disponível

E-health effectiveness to increase patient adherence for immunotherapy: A cost-benefit study

Dias, M.J.S. ; Fernández, P. ; Sousa, P. ; Rocha Gonçalves, F. ; Férnandez, E.

Texto completo disponível

223P Pregnancy-associated breast cancer: A single centre experience

Peixoto, I. ; Ramos, M.J. ; Ranchor, R. ; Romão, R. ; Mendes, A.S. ; Simões, J. ; Gonçalves, F. ; Alves, J.R. ; Ferreira, G. ; Polónia, J. ; Afonso, N. ; Araújo, A.

Elsevier Ltd

Texto completo disponível

Treatment (Tx) patterns and overall survival (OS) in patients (pts) with stage IIIB–IV NSCLC in Portugal: An IPO-PORTO database analysis from the I-O Optimise initiative

Soares, M.A.S. ; Antunes, L. ; Redondo, P. ; Borges, M. ; Hermans, R. ; Patel, D. ; Grimson, F. ; Munro, R. ; Chaib, C. ; Lacoin, L. ; Daumont, M. ; Penrod, J.R. ; O’Donnell, J.C. ; Bento, M.J. ; Goncalves, F.R.

England: Elsevier Ltd

Texto completo disponível

CN6E-health effectiveness to increase patient adherence for immunotherapy: A cost-benefit study

Dias, M J S ; Fernández, P ; Sousa, P ; Rocha Gonçalves, F ; Férnandez, E

Oxford University Press

Texto completo disponível

45PTreatment (Tx) patterns and overall survival (OS) in patients (pts) with stage IIIB–IV NSCLC in Portugal: An IPO-PORTO database analysis from the I-O Optimise initiative

Soares, M A S ; Antunes, L ; Redondo, P ; Borges, M ; Hermans, R ; Patel, D ; Grimson, F ; Munro, R ; Chaib, C ; Lacoin, L ; Daumont, M ; Penrod, J R ; O’Donnell, J C ; Bento, M J ; Goncalves, F R

Oxford University Press

Texto completo disponível

A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1)

Bonnefoi, H. ; Grellety, T. ; Tredan, O. ; Saghatchian, M. ; Dalenc, F. ; Mailliez, A. ; L'Haridon, T. ; Cottu, P. ; Abadie-Lacourtoisie, S. ; You, B. ; Mousseau, M. ; Dauba, J. ; Del Piano, F. ; Desmoulins, I. ; Coussy, F. ; Madranges, N. ; Grenier, J. ; Bidard, F.C. ; Proudhon, C. ; MacGrogan, G. ; Orsini, C. ; Pulido, M. ; Gonçalves, A.

England: Elsevier Ltd

Texto completo disponível

Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer

M-Rabet, M. ; Cabaud, O. ; Josselin, E. ; Finetti, P. ; Castellano, R. ; Farina, A. ; Agavnian-Couquiaud, E. ; Saviane, G. ; Collette, Y. ; Viens, P. ; Gonçalves, A. ; Ginestier, C. ; Charafe-Jauffret, E. ; Birnbaum, D. ; Olive, D. ; Bertucci, F. ; Lopez, M.

England: Elsevier Ltd

Texto completo disponível

BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer

Gonçalves, A. ; Gilabert, M. ; François, E. ; Dahan, L. ; Perrier, H. ; Lamy, R. ; Re, D. ; Largillier, R. ; Gasmi, M. ; Tchiknavorian, X. ; Esterni, B. ; Genre, D. ; Moureau-Zabotto, L. ; Giovannini, M. ; Seitz, J-F. ; Delpero, J-R. ; Turrini, O. ; Viens, P. ; Raoul, J-L.

Oxford: Elsevier Ltd

Texto completo disponível

Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: cross-over analysis from the SHIVA trial

Belin, L. ; Kamal, M. ; Mauborgne, C. ; Plancher, C. ; Mulot, F. ; Delord, J.-P. ; Gonçalves, A. ; Gavoille, C. ; Dubot, C. ; Isambert, N. ; Campone, M. ; Trédan, O. ; Ricci, F. ; Alt, M. ; Loirat, D. ; Sablin, M.-P. ; Paoletti, X. ; Servois, V. ; Le Tourneau, C.

England: Elsevier Ltd

Texto completo disponível